[ad_1]
Photographer: Hans Pennink / AP Photo
Photographer: Hans Pennink / AP Photo
Biotech company riceOn the 16th, Moderna announced a preliminary analysis result that the new coronavirus vaccine was effective in the third phase of a large-scale clinical trial with a probability of 94.5%. Efforts by scientists and pharmaceutical companies to rush to develop powerful tools to help curb pandemics are paying off.
MeterPfizer and GermanySimilar promising results were shown last week for the vaccine developed by Biontech. These vaccines are based on a technique called messenger RNA (mRNA).
Moderna analyzes data from more than 30,000 volunteer subjects. Virtually all symptomatic infections were avoided, according to the company statement.
According to the Data Security Oversight Commission (DSMB), an independent organization designated by the National Institutes of Health (NIH), only five of the two vaccinated subjects were infected and were vaccinated with counterfeit drugs. There were 90 people in the group.
The vaccine can also help prevent exacerbation. Modelna announced that there were no seriously ill patients in the vaccinated subjects, but there were 11 groups of bogus drugs. “I’m very excited about the aggravation data and I think it will change the situation,” said Stephen Bansel, CEO, in an interview.
In the United States, the number of new corona infections surpassed 11 million on the 15th, and the number of deaths and hospitalizations is increasing. The number of infected people is also increasing in Europe and the world is preparing for a miserable winter.
Both Moderna and Pfizer are expected to apply for an emergency use permit (US) from the US Food and Drug Administration (FDA) if safety is confirmed in future tests after receiving tentative but promising results. According to the announcement, Moderna could submit its application in a few weeks.
The company expects the EUA to be approved based on a final analysis of 151 cases and two months of safety monitoring data. Final data is expected to be released within a month.
Original title:Modern vaccine is considered highly effective in preventing Covid-19 （抜 粋）
